We are very proud to have been in the legal team lead by Willkie Farr & Gallagher LLP Germany that advised PAI Partners (“PAI”) on the acquisition of the majority stake in VAMED Group’s rehabilitation business (“VAMED”) from Fresenius SE & Co. KGaA.

On HAVEL & PARTNERS side, the professionals involved in the transaction were Martin Peckl (partner), Kateřina Slavíková (partner), David Šmída (counsel), Silvie Király (senior associate), Adam Karban (senior associate), and Hana Erbsová (associate).

VAMED’s rehabilitation business operates 67 clinics and care centers across Germany, Austria, Switzerland, the Czech Republic and the UK, serving more than 100,000 patients annually. Supported by around 10,000 highly-skilled staff, the unit provides a comprehensive range of inpatient and outpatient rehabilitation services, as well as specialist acute care. The business follows a multidisciplinary approach to patient care, with areas of expertise including neurology, orthopedics, psychosomatics, and cardiology.

PAI Partners is a pre-eminent private equity firm investing in market-leading companies across the globe. The Firm has approx. €27 billion of assets under management and, since 1994, has completed over 100 investments in 12 countries and realized more than €24 billion in proceeds from 60 exits. PAI has built an outstanding track record through partnering with ambitious management teams where its unique perspective, unrivalled sector experience, and long-term vision enable companies to pursue their full potential – and push beyond.

The completion of the transaction is expected for the second half of 2024 and is subject to customary regulatory approvals and closing conditions,